Shuttle Pharma to acquire United Dogecoin in merger, raises $11M in PIPE financing

Filed May 1, 2026 · Period ending April 30, 2026 · ~2 min read

Key Changes

• high

  Shuttle signed definitive merger agreement to acquire United Dogecoin Inc., with closing expected May 4, 2026. United Dogecoin shareholders will receive newly issued Series B-1 convertible preferred stock, with each preferred share converting into 4,033 common shares at $1.24. Sellers may receive up to 118 million additional pre-funded warrants upon hitting milestones.

  Item 1.01: Merger Agreement verify on EDGAR →
• high

  Concurrent $11 million PIPE financing through Series B-2 preferred stock convertible into approximately 9.7 million common shares at $1.03, plus warrants for 100% coverage at $1.03 exercise price. PIPE investors may receive up to 35 million additional milestone shares if performance targets are met.

  Item 1.01: PIPE Financing verify on EDGAR →
• high

  United Dogecoin CEO Ryan Trasolini will become Co-CEO of Shuttle at closing. Shuttle must transfer its existing pre-merger assets and liabilities to a newly established subsidiary within 15 business days, creating a holding company structure where legacy Shuttle operates as a subsidiary.

  Item 1.01: Management Changes verify on EDGAR →